Skip directly to content

Corporate Sponsorships January to June 2011

on Wed, 06/08/2016 - 22:38

Arthritis NSW

Arthritis NSW was established over 40 years ago to provide education, support and services to people in the community living with arthritis and other musculoskeletal conditions. More than 3.1 million Australians have arthritis. Arthritis NSW supports people of all ages and provides information to people who have been newly diagnosed with the disease, as well as those who have lived with it some time. Arthritis NSW also works with health care professionals to improve management of arthritis, and supports research into the causes and treatment of arthritis.
 
In 2011 Pfizer provided $4,500 to Arthritis NSW by sponsoring ‘Splash for Arthritis’, Australia’s biggest water class.  This event launched Arthritis Awareness Week in February and was held at the Ian Thorpe Aquatic Centre in Pyrmont.

The Australian Lung Foundation

The Australian Lung Foundation was established in 1990 by a group of thoracic physicians concerned about the chronic shortage of funds for research work in respiratory medicine and the impact of lung disease on our community. The aim of The Australian Lung Foundation is to ‘ensure lung health is a priority for all in Australia’ through the provision of:

  • Leadership
  • Advocacy
  • Information
  • Support and research
  • Patient and carer support
  • Education and training
  • And…through working with and through other organisations.

 
In mid 2011 Pfizer Australia supported The Australian Lung Foundation by contributing $10,000 to the Kylie Johnston Lung Cancer Network (KJLCN). This funding will cover 12 months. A major focus for the KJLCN is the development of support networks (face to face support groups and phone and internet support) for those burdened by lung cancer and their families and carers.

The Australian Pituitary Foundation

The Australian Pituitary Foundation (APF) was founded in 1994 by pituitary patients and family members, with the endorsement of Australian endocrinologists, neurosurgeons, radiation therapists and endocrine nurses, who saw the need to support people who have rare conditions of the pituitary gland. The APF is a benevolent society and it now operates through a national committee and State branches.  The APF’s mission is to provide support to people and their families with pituitary gland conditions.  The APF also partners with organisations to promote awareness, lobby and disseminate information among the medical and general communities.   
 
In 2011 Pfizer Australia provided $17,000 to support the APF by funding educational seminars, the development of paediatric posters and the development and maintenance of the APF’s website.

Mental Illness Fellowship of Australia

The Mental Illness Fellowship of Australia (MIFA) is a national body providing services in all Australian states and territories. MIFA is a non-government, not-for-profit, self-help, support and advocacy organisation dedicated to helping people with serious mental illnesses, their families and friends. MIFA’s vision is to create inclusive, resilient and mentally healthy communities.
 
In 2011 Pfizer Australia provided $12,000 to support the MIFA fund a study to examine the experiences of siblings who have a brother or sister with mental illness including the daily challenges and life benefits. The findings from this study will aid in developing a guideline for best practice for support needs for siblings of people with mental illness for MIFA and its member organisations.

Painaustralia

Painaustralia is the national not-for-profit organisation which aims to improve the quality of life of people living with pain and their families, to minimise the burden of pain on individuals and the community by working with consumers, health care professionals and State and Federal Governments to implement the recommendations of the National Pain Strategy. The National Pain Strategy is the result of 18 months work by over 150 health care professionals, people who live with pain, and not-for-profit bodies representing a broad range of health issues, including chronic diseases associated with pain, such as arthritis and cancer.
 
In 2011 Painaustralia established the ‘Painaustralia Collaboration’ with Pfizer Australia and other leading pharmaceutical companies. The main aim of this collaboration is to raise awareness of chronic pain as a disease in its own right and promote the need for improved pain services. Funding from the collaboration will assist Painaustralia in developing and implementing a Communications Strategy, ensuring consumers and health care professionals have access to current quality information and resources, developing a register of pain clinical research, developing a quarterly newsletter to ensure stakeholders are aware of national and global pain initiatives and the hosting of the Painaustralia Conference.
 
In 2011 Pfizer Australias contributed $56,925 to the collaboration.

Tour de Cure

The Tour de Cure is a cycling foundation committed to raising money to help fund vital cancer research, support and prevention projects. Through engaging Australian communities Tour de Cure's aim is to raise awareness and inspire action in the fight against cancer. Tour de Cure’s signature annual cycling Tour celebrates their fundraising efforts and sees a group of ordinary people embark on an extraordinary journey between two Australian cities. In 2011 the Tour de Cure rode from Sydney to Melbourne via the Snowy Mountains visiting 14 schools and sharing the cancer awareness with over 2500 kids aged 6-12.
 
Pfizer Oncology’s 2011 sponsorship of the Tour de Cure was $60,000. This funding covers:

  • Team and Category Jersey – Purple jersey for Cure for Life Foundation (awarded daily)
  • Gold Partner of “A Day of Inspiration 2011” held in February 2011
  • Primary Partner of the adult cancer awareness book “What I wish I knew about Cancer”
  • Staff engagement; 1 rider and 5 guest rider positions for the 2011 tour
  • Team naming rights on rider’s jersey

The Unicorn Foundation

The Unicorn Foundation is the only Australian not-for-profit medical charity focussed on neuroendocrine tumours (NET). The Unicorn Foundation aims to educate and support Australian sufferers of NET and their families by increasing their awareness and knowledge of the disease. It also aims to direct donations to Australian researchers and institutions who will work towards a cure for this rare and unpopular group of cancers.
 
 In 2011 the Unicorn Foundation formed a partnership with Pfizer Australia, Novartis and Ipsem. The aim of this collaboration is to increase awareness and build knowledge about neuroendocrine cancers. This awareness-raising campaign will focus on:

  • Assessing GP knowledge of neuroendocrine tumours
  • Developing educational material for a GP sample group
  • Promoting the Unicorn Foundation as a peak body, a resource and an advocacy group

In 2011 Pfizer Australia contributed $8,000.